PF-Atlas › Clinical Trials › NCT06939504

A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects

HRS-9813 Capsule · Phase 1

Registry ID
NCT06939504
Phase
Phase 1
Status
Completed
Drug / intervention
HRS-9813 Capsule
Sponsor
Guangdong Hengrui Pharmaceutical Co., Ltd
Start
2025-05-04

About this trial

HRS-9813 Capsule is evaluated in NCT06939504, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Guangdong Hengrui Pharmaceutical Co., Ltd. Current status: Completed.

View NCT06939504 on ClinicalTrials.gov →

Explore related

All HRS-9813 Capsule trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT06939504 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.